UK Government Plays Matchmaker In GSK/Novavax Deal To ‘Onshore’ COVID-19 Vaccine Production
Comes Amid Tensions With EU
The UK wants to consolidate its rapid vaccine roll-out and its domestic supply chain via the alliance
You may also be interested in...
Moderna Makes Major mRNA Commitment To UK
The US biotech major has unveiled plans to open a new research and manufacturing center in the UK, which signals the start of detailed talks with the government about establishing a long-term partnership.
UK As New Global Base, Serum Institute Mulls Acquisition Or Greenfield Unit
After setting up a sales base in the UK, Serum Institute could consider an acquisition in Europe or investment in an Oxford facility as it ties up production for its multiple COVID-19 vaccines. Is Wockhardt’s Wrexham facility an option?
Lilly And GSK/Vir Antibody Combo Reduces COVID-19 Viral Load
Top-line Phase II data show that a combo of bamlanivimab and VIR-7831, neutralizing antibodies to the SARS-CoV-2 spike protein, yielded a relative 70% reduction in viral load.